Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

A. Rutten · SciRah

Researcher profile · Semantic Scholar

A. Rutten

Share profile

A. Rutten — researcher profile on SciRah

h-index: 23
Works: 61
Citations: 2,636

Most-cited papers

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
F. Bidard, D. Peeters, T. Fehm, F. Nolè +39 more
2014The Lancet Oncology788 citations
Semantic Scholar
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.
M. Cristofanilli, J. Pierga, J. Reuben, A. Rademaker +45 more
2019Critical reviews in oncology/hematology252 citations Open access
Semantic Scholar
Semiautomated isolation and molecular characterisation of single or highly purified tumour cells from CellSearch enriched blood samples using dielectrophoretic cell sorting
D. Peeters, B. De Laere, G. G. Van den Eynden, S. V. van Laere +10 more
2013British Journal of Cancer162 citations Open access
Semantic Scholar
TP53 outperforms other androgen receptor biomarkers to predict abiraterone or enzalutamide outcome in metastatic castration-resistant prostate cancer
B. De Laere, Steffi Oeyen, M. Mayrhofer, Thomas Whitington +33 more
2018Clinical Cancer Research159 citations Open access
Semantic Scholar
A randomized trial comparing adjuvant fluorouracil, doxorubicin, and mitomycin with no treatment in operable gastric cancer. International Collaborative Cancer Group.
R. Coombes, P. Schein, C. Chilvers, Jacques A. Wils +6 more
1990Journal of Clinical Oncology139 citations
Semantic Scholar
Cell-free DNA profiling of metastatic prostate cancer reveals microsatellite instability, structural rearrangements and clonal hematopoiesis
M. Mayrhofer, B. De Laere, Thomas Whitington, P. van Oyen +28 more
2018Genome Medicine120 citations Open access
Semantic Scholar
Safety and efficacy of AMG 820, an anti-colony-stimulating factor 1 receptor antibody, in combination with pembrolizumab in adults with advanced solid tumors
Albiruni Razak, J. Cleary, V. Moreno, M. Boyer +17 more
2020Journal for ImmunoTherapy of Cancer115 citations Open access
Semantic Scholar
Multidisciplinary molecular tumour board: a tool to improve clinical practice and selection accrual for clinical trials in patients with cancer
C. Rolfo, P. Manca, R. Salgado, P. V. van Dam +13 more
2018ESMO Open86 citations Open access
Semantic Scholar
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial
D. Petrylak, R. de Wit, K. Chi, A. Drakaki +142 more
2019The Lancet Oncology78 citations Open access
Semantic Scholar
Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis
E. de Azambuja, M. Brandão, H. Wildiers, A. Laenen +14 more
2020ESMO Open74 citations Open access
Semantic Scholar
Detection and prognostic significance of circulating tumour cells in patients with metastatic breast cancer according to immunohistochemical subtypes
D. Peeters, P. van Dam, G. G. Van den Eynden, A. Rutten +8 more
2013British Journal of Cancer68 citations Open access
Semantic Scholar
Blood microvessel density, lymphatic microvessel density and lymphatic invasion in predicting melanoma metastases: systematic review and meta‐analysis
I. Pastushenko, Peter Vermeulen, F. J. Carapeto, G. G. Van den Eynden +4 more
2014British Journal of Dermatology57 citations
Semantic Scholar
A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial.
R. Galot, C. le Tourneau, E. Saâda-Bouzid, A. Daste +21 more
2021European Journal of Cancer51 citations Open access
Semantic Scholar
Trastuzumab Deruxtecan with Nivolumab in HER2-Expressing Metastatic Breast or Urothelial Cancer: Analysis of the Phase Ib DS8201-A-U105 Study
E. Hamilton, M. Galsky, S. Ochsenreither, G. Del Conte +23 more
2024Clinical Cancer Research50 citations Open access
Semantic Scholar
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study.
D. Schadendorf, M. Amonkar, M. Milhem, K. Grotzinger +17 more
2014Annals of Oncology48 citations Open access
Semantic Scholar
First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors
T. W. Kim, H. Burris, M. D. De Miguel Luken, M. Pishvaian +21 more
2022Clinical Cancer Research42 citations Open access
Semantic Scholar
Effect of Food on the Pharmacokinetics of Olaparib after Oral Dosing of the Capsule Formulation in Patients with Advanced Solid Tumors
C. Rolfo, H. Swaisland, K. Leunen, A. Rutten +7 more
2015Advances in Therapy41 citations Open access
Semantic Scholar
Circulating tumour cells and lung microvascular tumour cell retention in patients with metastatic breast and cervical cancer.
D. Peeters, Anja Brouwer, G. G. Van den Eynden, A. Rutten +8 more
2015Cancer Letters34 citations
Semantic Scholar
162O Primary analysis from DS8201-A-U105: A 2-part, open label, phase Ib trial assessing trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing advanced breast cancer
E. Hamilton, C. L. Shapiro, V. Boni, M. M. Jiménez +16 more
2022Annals of Oncology31 citations Open access
Semantic Scholar
A phase I study (E011-MEL) of a TriMix-based mRNA immunotherapy (ECI-006) in resected melanoma patients: Analysis of safety and immunogenicity.
A. A. Arance Fernandez, J. Baurain, C. Vulsteke, A. Rutten +6 more
2019Journal of Clinical Oncology26 citations
Semantic Scholar
A nationwide comprehensive genomic profiling and molecular tumor board platform for patients with advanced cancer
P.-J. Volders, P. Aftimos, F. Dedeurwaerdere, G. Martens +27 more
2025npj Precision Oncology25 citations Open access
Semantic Scholar
Abstract PD3-07: Trastuzumab deruxtecan (T-DXd; DS-8201) with nivolumab in patients with HER2-expressing, advanced breast cancer: A 2-part, phase 1b, multicenter, open-label study
E. Hamilton, C. Shapiro, D. Petrylak, V. Boni +15 more
2021Poster Spotlight Session Abstracts24 citations
Semantic Scholar
Circulating tumor cells and survival in abiraterone‐ and enzalutamide‐treated patients with castration‐resistant prostate cancer
B. De Laere, Steffi Oeyen, P. van Oyen, C. Ghysel +24 more
2018The Prostate23 citations Open access
Semantic Scholar
Mechanisms of tumour vascularization in cutaneous malignant melanoma: clinical implications
I. Pastushenko, P. Vermeulen, G. G. Van den Eynden, A. Rutten +3 more
2014British Journal of Dermatology18 citations Open access
Semantic Scholar
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment
J. Thouvenin, C. van Marcke, L. Decoster, G. Raicevic +39 more
2022ESMO Open13 citations Open access
Semantic Scholar
Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
T. Van Meerhaeghe, J. Baurain, O. Bechter, C. O. Cano +10 more
2022Frontiers in Nephrology12 citations Open access
Semantic Scholar
Peritumoral D2‐40 Chalkley score independently predicts metastases and survival in patients with cutaneous malignant melanoma
I. Pastushenko, Peter Vermeulen, S. Vicente-Arregui, G. G. Van den Eynden +6 more
2015Journal of cutaneous pathology12 citations
Semantic Scholar
Vismodegib: a promising drug in the treatment of basal cell carcinomas.
L. Dirix, A. Rutten
2012Future Oncology11 citations
Semantic Scholar
A phase II study of monalizumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R. Galot, C. le Tourneau, E. Saada-Bouzid, A. Daste +16 more
2019Annals of Oncology10 citations Open access
Semantic Scholar
A phase I trial of LHC165 single agent and in combination with spartalizumab in patients with advanced solid malignancies
G. Curigliano, M. Jiménez, T. Shimizu, B. Keam +14 more
2024ESMO Open9 citations Open access
Semantic Scholar
Trastuzumab emtansine in breast cancer
L. Dirix, A. Rutten, P. Huget, M. Dirix
2013Expert Opinion on Biological Therapy9 citations
Semantic Scholar
Trastuzumab emtansine in advanced human epidermal growth factor receptor 2-positive breast cancer
T. V. D. van den Mooter, L. Teuwen, A. Rutten, L. Dirix
2015Expert Opinion on Biological Therapy8 citations
Semantic Scholar
Abstract CT103: Phase I study of LHC165 ± spartalizumab (PDR001) in patients (pts) with advanced solid tumors
G. Curigliano, M. Jiménez, Toshio Shimizu, B. Keam +10 more
2021Clinical Trials7 citations
Semantic Scholar
Functional and symptom impact of trametinib versus chemotherapy in BRAF V600E advanced or metastatic melanoma: quality-of-life analyses of the METRIC study.
D. Schadendorf, M. Amonkar, M. Milhem, K. Grotzinger +17 more
20147 citations Open access
Semantic Scholar
Effect of food on the pharmacokinetics (PK) of olaparib after oral dosing of the capsule formulation.
I. Vergote, A. Rutten, C. Rolfo, P. Soetekouw +7 more
20146 citations
Semantic Scholar
Ipilimumab and nivolumab plus UV1, an anticancer vaccination against telomerase, in advanced melanoma.
P. Lorigan, Theresa M. Medina, M. Nyakas, A. Rutten +11 more
2024Journal of Clinical Oncology5 citations
Semantic Scholar
A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R. Galot, C. le Tourneau, L. Licitra, J. Guigay +21 more
2025ESMO Open4 citations Open access
Semantic Scholar
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future
T. Geukens, M. Brandão, A. Laenen, J. Collignon +24 more
2022ESMO Open4 citations Open access
Semantic Scholar
Pneumocystis jiroveci pneumonia (PJP) in non-HIV immunocompromised individuals
K. Schoovaerts, L. Dirix, A. Rutten, Jef Van Schaeren +3 more
2017Acta Clinica Belgica4 citations
Semantic Scholar
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study.
P. Lorigan, Theresa M. Medina, M. Nyakas, A. Rutten +14 more
2025European Journal of Cancer3 citations
Semantic Scholar
935P A phase II study of monalizumab and durvalumab in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN): Results of the I2 cohort of the EORTC-HNCG-1559 trial (UPSTREAM)
R. Galot, C. le Tourneau, L. Licitra, C. Even +16 more
2023Annals of Oncology3 citations Open access
Semantic Scholar
Abstract PD6-5: Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data
F. Bidard, D. Peeters, T. Fehm, F. Nolè +39 more
20132 citations
Semantic Scholar
Abstract P2-01-09: Tumor cell emboli in the lung and transcriptional profiles of circulating tumor cells derived from different vascular compartments in patients with metastatic breast cancer.
D. Peeters, G. G. Van den Eynden, A. Rutten, Wendy Onstenk +8 more
20122 citations
Semantic Scholar
Patients with metastatic hormone receptor-positive breast cancer express PIK3CA oncogene mutational heterogeneity in circulating tumor cells
B. De Laere, D. Peeters, Anja Brouwer, R. Salgado +8 more
20161 citations Open access
Semantic Scholar
Geneo study: Comprehensive genomic profiling versus limited local reimbursed NGS panels within the belgian Precision initiative.
G. R. Toungouz, A. Hébrant, S. Nannini, C. van Marcke +21 more
2026European Journal of Cancer0 citations
Semantic Scholar
Personalized biomarker-based treatment strategy in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Results of the biomarker-driven cohorts of the EORTC-HNCG-1559 trial (UPSTREAM).
R. Galot, C. le Tourneau, L. Licitra, J. Guigay +16 more
2025Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Afatinib in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN) harboring alterations in the HER pathway: Results of the B1 cohort of the EORTC-HNCG-1559 trial (UPSTREAM).
R. Galot, C. le Tourneau, L. Licitra, A. Daste +16 more
2023Journal of Clinical Oncology0 citations Open access
Semantic Scholar
Corrigendum: Cemiplimab for advanced cutaneous squamous cell carcinoma in kidney transplant recipients
T. Van Meerhaeghe, J. Baurain, O. Bechter, C. O. Cano +10 more
2023Frontiers in Nephrology0 citations Open access
Semantic Scholar
77P The Belgian Multidisciplinary Immunotoxicity Board (BITOX): A nationwide initiative of the Belgian Society of Medical Oncology (BSMO)
M. Verhaert, S. Aspeslagh, O. Bechter, S. Wuyts +9 more
2021Annals of Oncology0 citations Open access
Semantic Scholar
Sensitivity and dynamic range of CellSearch based CSF DTC enumeration in patients with breast cancer related leptomeningeal metastases (LM).
A. Van Goethem, C. Rypens, A. Rutten, T. V. D. van den Mooter +6 more
2019Annals of Oncology0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Dirix×17
Invite
L. Dirix — researcher profile on SciRah
S. V. van Laere×13
Invite
S. V. van Laere — researcher profile on SciRah
G. G. Van den Eynden×11
Invite
G. G. Van den Eynden — researcher profile on SciRah
S. Rottey×9
Invite
S. Rottey — researcher profile on SciRah

×8

Invite

D. Peeters — researcher profile on SciRah

Invite

W. Demey — researcher profile on SciRah

Invite

W. Lybaert — researcher profile on SciRah

Invite

B. De Laere — researcher profile on SciRah

Invite

R. Galot — researcher profile on SciRah

C. le Tourneau×6

Invite

C. le Tourneau — researcher profile on SciRah

Invite

A. Daste — researcher profile on SciRah

D. Schrijvers×5

Invite

D. Schrijvers — researcher profile on SciRah